Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.
Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk.
复制标题
DOI:
10.1016/j.ccr.2011.09.011
复制
发表时间:
2011-11-15
期刊:
影响因子:
50.3
通讯作者:
Bhatia R
中科院分区:
文献类型:
--
作者:
Li L;Li M;Sun C;Francisco L;Chakraborty S;Sabado M;McDonald T;Gyorffy J;Chang K;Wang S;Fan W;Li J;Zhao LP;Radich J;Forman S;Bhatia S;Bhatia R
Therapy-related myelodysplasia or acute myeloid leukemia (t-MDS/AML) is a major complication of cancer treatment. We compared gene expression in CD34+ cells from patients who developed t-MDS/AML after autologous hematopoietic cell transplantation (aHCT) for lymphoma with controls who did not develop t-MDS/AML. We observed altered gene expression related to mitochondrial function, metabolism, and hematopoietic regulation in pre-aHCT samples from patients who subsequently developed t-MDS/AML. Progression to overt t-MDS/AML was associated with additional alterations in cell-cycle regulatory genes. An optimal 38-gene PBSC classifier accurately distinguished patients who did or did not develop t-MDS/AML in an independent group of patients. We conclude that genetic programs associated with t-MDS/AML are perturbed long before disease onset, and accurately identify patients at risk for this complication.
登录
查看更多内容
影响因子:
4.3
作者:
Grivennikova, Vera G.;Vinogradov, Andrei D.
通讯作者:
Vinogradov, Andrei D.
影响因子:
64.8
作者:
Ebert, Benjamin L.;Pretz, Jennifer;Bosco, Jocelyn;Chang, Cindy Y.;Tamayo, Pablo;Galili, Naomi;Raza, Azra;Root, David E.;Attar, Eyal;Ellis, Steven R.;Golub, Todd R.
通讯作者:
Golub, Todd R.
影响因子:
45.3
作者:
Kalaycio, Matt;Rybicki, Lisa;Bolwell, Brian
通讯作者:
Bolwell, Brian
影响因子:
50.3
作者:
Feldser, David M.;Greider, Carol W.
通讯作者:
Greider, Carol W.
影响因子:
20.3
作者:
Faber, P;Fisch, P;Spyridonidis, A
通讯作者:
Spyridonidis, A